trial · primary record
Cyclophosphamide
Pancreatic Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 124 |
| Primary completion | 2030-01-01 |
| Primary endpoint | Frequency and severity of treatment-related adverse events |
| Registry ID | NCT02830724 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:18.955Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02830724
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.